{"meta":{"query_hash":"6f1bcde6a7fb","filters":{"venue":"Minerva Urologica e Nefrologica"},"cohort_total":5,"direct_labels_cover":1,"predictions_cover":5,"exported":5,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6f1bcde6a7fb","api":"https://metacan.xera.ac/api/v1/cohort?venue=Minerva+Urologica+e+Nefrologica"},"results":[{"id":"W2906285891","doi":"10.23736/s0393-2249.18.03295-2","title":"Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease","year":2018,"lang":"en","type":"editorial","venue":"Minerva Urologica e Nefrologica","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Urology; Management of prostate cancer; Disease; Oncology; General surgery; Internal medicine; Cancer","score_opus":0.019730439347039257,"score_gpt":0.2981216629365001,"score_spread":0.27839122358946083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906285891","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048781258,0.036695182,0.00010107354,0.033882402,0.9285581,0.0000137802635,0.000036786292,0.00002064888,0.0006433246],"genre_scores_gemma":[0.0003361942,0.018778978,0.000087116736,0.011193533,0.9680687,0.000009984873,0.000018231218,0.000009572661,0.0014976261],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959971,0.0009237743,0.0009193974,0.00036559993,0.0015735193,0.00022070999],"domain_scores_gemma":[0.97434276,0.014758444,0.0014398984,0.00036472554,0.0072019547,0.0018921965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00875239,0.0030142844,0.004782618,0.0025159735,0.001846395,0.0046720426,0.003853011,0.014721703,0.004104408],"category_scores_gemma":[0.024086943,0.0011613512,0.0032087197,0.001174566,0.0018678041,0.003925595,0.0011749873,0.025754027,0.0031345468],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018917235,0.00003912689,0.0000844353,0.001260099,0.000116591844,0.00023791383,0.000029105044,0.00008095406,0.00010472238,0.00054246106,0.973465,0.023850352],"study_design_scores_gemma":[0.0003560128,0.000144199,0.00096523366,0.002578353,0.00048122427,0.00069293426,0.00008165422,0.00029980854,0.00020901008,0.0015042634,0.99263656,0.00005069842],"about_ca_topic_score_codex":0.0023717957,"about_ca_topic_score_gemma":0.00594374,"teacher_disagreement_score":0.014721703,"about_ca_system_score_codex":0.0031816093,"about_ca_system_score_gemma":0.0032594178,"threshold_uncertainty_score":0.046287596},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2980514435","doi":"10.23736/s0393-2249.19.03583-5","title":"Robotic partial nephrectomy versus radical nephrectomy in elderly patients with large renal masses","year":2020,"lang":"en","type":"article","venue":"Minerva Urologica e Nefrologica","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Nephrectomy; Propensity score matching; Logistic regression; Urology; Renal mass; Internal medicine; Proportional hazards model; Renal function; Blood loss; Surgery; Kidney","score_opus":0.03253246135949481,"score_gpt":0.2441733649853707,"score_spread":0.2116409036258759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980514435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980312,0.0015016443,0.00012806908,0.000078346144,0.000025646568,0.0000053377335,0.000039574756,0.000001979895,0.00018810453],"genre_scores_gemma":[0.9994343,0.0003112517,0.00007203192,0.00004505563,0.000045382596,0.000004290135,0.00005597091,4.5511837e-7,0.000031378488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997769,0.00009353436,0.000024878484,0.000039023213,0.000029971112,0.000035698587],"domain_scores_gemma":[0.9991792,0.00027201432,0.00030384396,0.000026652153,0.000018102724,0.00020021836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007101484,0.00012439735,0.0003418175,0.00015937017,0.00014473785,0.0002627356,0.0001227222,0.00016187546,0.0008040411],"category_scores_gemma":[0.0022689158,0.000057983678,0.0005200397,0.00015524786,0.00014765827,0.00022201869,0.0003003385,0.00016681796,0.00007515656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012830603,0.00023427086,0.93269753,0.00019619367,0.0008229577,0.0005266226,0.00008585087,0.000976232,0.0010220774,0.00013384451,0.0005100985,0.049963597],"study_design_scores_gemma":[0.00050157605,0.007963699,0.98554695,0.00007961253,0.0005077131,0.0018407837,0.00021878952,0.0017623684,0.00034281914,0.00030178906,0.00092083175,0.00001306374],"about_ca_topic_score_codex":0.0002734676,"about_ca_topic_score_gemma":0.0006977401,"teacher_disagreement_score":0.0008040411,"about_ca_system_score_codex":0.00017236207,"about_ca_system_score_gemma":0.00022984177,"threshold_uncertainty_score":0.003755629},"labels":[],"label_agreement":null},{"id":"W2981571673","doi":"10.23736/s0393-2249.19.03420-9","title":"Bone-targeted therapy in castration-resistant prostate cancer: where do we stand?","year":2019,"lang":"en","type":"review","venue":"Minerva Urologica e Nefrologica","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Denosumab; Prostate cancer; Zoledronic acid; Oncology; Enzalutamide; Docetaxel; Dosing; Internal medicine; Cabozantinib; Cancer; Osteoporosis; Androgen receptor","score_opus":0.1022234460612595,"score_gpt":0.37831971787205093,"score_spread":0.27609627181079144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981571673","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008311044,0.9970059,0.000042366435,0.0024282595,0.00028574132,0.000005874028,0.000021511398,0.0000024144513,0.0001248821],"genre_scores_gemma":[0.0019622855,0.9953029,0.00018341368,0.0016778277,0.000701831,0.00001590546,0.000028796316,0.0000022217853,0.00012475562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970692,0.001189963,0.00061495777,0.00033884068,0.000660771,0.00012626847],"domain_scores_gemma":[0.9836385,0.010758302,0.0024609047,0.0001902711,0.0026568458,0.00029510318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007331813,0.0008483847,0.0044889795,0.002818651,0.00048875314,0.0031335186,0.0015723215,0.0029805056,0.004610128],"category_scores_gemma":[0.01606469,0.00044282526,0.002119265,0.0041901553,0.0014496035,0.0043339953,0.0009599106,0.0028160026,0.0009513298],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007777377,0.00006433146,0.0009348477,0.35544667,0.0015747627,0.0001878735,0.00036851404,0.00042527536,0.0004980026,0.0052821822,0.02894193,0.60549784],"study_design_scores_gemma":[0.00027384772,0.000772304,0.0038113056,0.5328558,0.004468385,0.0008922399,0.0010941427,0.00032817348,0.00031012847,0.010552255,0.44454074,0.000100737285],"about_ca_topic_score_codex":0.0044970135,"about_ca_topic_score_gemma":0.00790332,"teacher_disagreement_score":0.007331813,"about_ca_system_score_codex":0.0020090826,"about_ca_system_score_gemma":0.0065320292,"threshold_uncertainty_score":0.038774848},"labels":[],"label_agreement":null},{"id":"W2990378832","doi":"10.23736/s0393-2249.19.03496-9","title":"Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Minerva Urologica e Nefrologica","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Propensity score matching; Urology; Nephrectomy; Internal medicine; Incidence (geometry); Surgery; Gastroenterology; Kidney","score_opus":0.03222223105910394,"score_gpt":0.27020822593485433,"score_spread":0.2379859948757504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990378832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736756,0.001462719,0.00032759103,0.00013898592,0.0000071839354,0.000014866037,0.000274618,0.0000054820375,0.00040097634],"genre_scores_gemma":[0.9993228,0.00019196903,0.00014944204,0.000026027325,0.000012272147,0.000009211824,0.00021813372,0.0000013946743,0.00006876652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906033,0.00038566033,0.00008769246,0.00020444795,0.00019526931,0.00006655493],"domain_scores_gemma":[0.99659914,0.0010553709,0.0016537126,0.0001175606,0.00019967812,0.0003745265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024980952,0.000118162105,0.00041038252,0.00041153844,0.00019143421,0.0005711774,0.00034790274,0.00024386027,0.0012044578],"category_scores_gemma":[0.005811476,0.00009354649,0.0008417179,0.00053164345,0.00022465293,0.00044094873,0.0004254054,0.0003926243,0.0001323859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011666864,0.000068900306,0.980773,0.00009646533,0.00029193805,0.000030964387,0.00005720273,0.00056193356,0.0002560487,0.00007511889,0.00017720387,0.016444525],"study_design_scores_gemma":[0.000037395763,0.0010504812,0.99497485,0.00003074461,0.00037248727,0.00025130415,0.00015296318,0.0018086092,0.00040977803,0.00020329989,0.0007014512,0.0000064842943],"about_ca_topic_score_codex":0.0016970541,"about_ca_topic_score_gemma":0.003266496,"teacher_disagreement_score":0.0024980952,"about_ca_system_score_codex":0.0008127979,"about_ca_system_score_gemma":0.00069237244,"threshold_uncertainty_score":0.01321131},"labels":[],"label_agreement":null},{"id":"W3109675067","doi":"10.23736/s0393-2249.20.04018-7","title":"Trimodal therapy in muscle invasive bladder cancer management","year":2020,"lang":"en","type":"review","venue":"Minerva Urologica e Nefrologica","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Radiation therapy; Quality of life (healthcare); Genitourinary system; Systematic review; Oncology; MEDLINE; Internal medicine; Cancer; Intensive care medicine; Surgery","score_opus":0.09081465935838906,"score_gpt":0.35122281061338156,"score_spread":0.2604081512549925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109675067","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010371532,0.9977285,0.00008448373,0.00038841134,0.00008082339,0.000012434094,0.000044986326,0.0000036298434,0.00061950216],"genre_scores_gemma":[0.043146987,0.9540812,0.00056800246,0.0011629894,0.00047730078,0.000068790825,0.00017885164,0.0000036128986,0.00031223145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994011,0.0002833371,0.00010117786,0.00008000233,0.00010969062,0.000024668705],"domain_scores_gemma":[0.9978514,0.001375882,0.0005423114,0.000029833247,0.00014731287,0.000053312702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011707095,0.00032064627,0.0010712373,0.0012119054,0.00016241196,0.00068492093,0.00052288955,0.0006877201,0.0057019102],"category_scores_gemma":[0.003635149,0.000121289966,0.0009254973,0.0010676419,0.0003181445,0.00058247015,0.00047344595,0.0007500766,0.00044487903],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012184486,0.000093349074,0.0012081218,0.2446785,0.0016708196,0.00023114627,0.000110056186,0.0006863215,0.0010318606,0.0011454881,0.0090836035,0.7388423],"study_design_scores_gemma":[0.0015373328,0.0048011104,0.028753605,0.5834221,0.0151302265,0.0065586986,0.0004844873,0.0012953186,0.003453829,0.0075242226,0.34693375,0.00010529987],"about_ca_topic_score_codex":0.0009321261,"about_ca_topic_score_gemma":0.0019512958,"teacher_disagreement_score":0.0057019102,"about_ca_system_score_codex":0.000646507,"about_ca_system_score_gemma":0.0009763579,"threshold_uncertainty_score":0.019074738},"labels":[],"label_agreement":null}]}